NYSE American - Delayed Quote USD

Scorpius Holdings, Inc. (SCPX)

Compare
0.3800
-0.0010
(-0.26%)
At close: January 10 at 4:00:00 PM EST
0.3750
-0.00
(-1.32%)
After hours: 7:58:19 PM EST
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for SCPX

Recent News: SCPX

View More
Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model

Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model
GlobeNewswire last month
Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability

Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability
GlobeNewswire last month
Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement

Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement
GlobeNewswire 2 months ago
Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually

Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually
GlobeNewswire 2 months ago
Scorpius Partners with Biotech Firm to Boost U.S. Biomanufacturing Capabilities

Scorpius Partners with Biotech Firm to Boost U.S. Biomanufacturing Capabilities
GuruFocus.com 2 months ago
Scorpius Holdings Announces Partnership with U.S. Biotech Company

Scorpius Holdings Announces Partnership with U.S. Biotech Company
GlobeNewswire 2 months ago
Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats

Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats
GlobeNewswire 3 months ago
Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities

Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities
GlobeNewswire 3 months ago
Scorpius Holdings Commends the U.S. House of Representatives’ Passage of the BIOSECURE Act

Scorpius Holdings Commends the U.S. House of Representatives’ Passage of the BIOSECURE Act
GlobeNewswire 3 months ago
Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA

Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA
GlobeNewswire 3 months ago
Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash Flow

Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash Flow
GlobeNewswire 4 months ago
View More

Related Tickers

CYCC Cyclacel Pharmaceuticals, Inc.
0.4199
+1.21%
 
BLRX BioLineRx Ltd.
0.1429
+0.21%
 
MBIO Mustang Bio, Inc.
0.2566
+15.38%
 
ONCO Onconetix, Inc.
0.5100
-6.68%
 
CDT Conduit Pharmaceuticals Inc.
0.1233
+50.37%
 
IMRX Immuneering Corporation
2.0700
+3.50%
 
SPRC SciSparc Ltd.
0.8149
+1.03%
 
SILO Silo Pharma, Inc.
1.7700
+3.51%
 
CNSP CNS Pharmaceuticals, Inc.
0.1178
+1.55%
 
NLSP NLS Pharmaceutics AG
2.3200
-3.73%